Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|April 23, 2014
Amikacin-fosfomycin at a five-to-two ratio: characterization of mutation rates in microbial strains causing ventilator-associated pneumonia and interactions with commonly used antibioticsA Bruce Montgomery, Paul R Rhomberg, Tammy Abuan, et al.
Clinical Genitourinary Cancer|July 13, 2017
Prostate Cancer Screening in a New Era of GeneticsHeather H Cheng, Colin C Pritchard, Bruce Montgomery, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2014
Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogensA Bruce Montgomery, Paul R Rhomberg, Tammy Abuan, et al.
Journal of the National Cancer Institute|November 7, 2002
Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibitionMichael J Bonham, Anna Galkin, Bruce Montgomery, et al.
Hormones & Cancer|July 16, 2011
Testosterone regulates tight junction proteins and influences prostatic autoimmune responsesJing Meng, Elahe A Mostaghel, Funda Vakar-Lopez, et al.
The Prostate|June 9, 2016
A Novel System for Estimating Residual Disease and Pathologic Response to Neoadjuvant Treatment of Prostate CancerClaire Murphy, Lawrence True, Funda Vakar-Lopez, et al.
JCO Precision Oncology|April 27, 2022
Homologous Recombination Repair Gene Variants and Outcomes Among Patients With Prostate Cancer Treated With Poly (ADP-ribose) Polymerase InhibitorsMeghan J Price, Vishal Vashistha, David Winski, et al.
Chest|May 19, 2009
Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infectionAlexandra L Quittner, Avani C Modi, Claire Wainwright, et al.
American Journal of Clinical Oncology|December 20, 2007
The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapyHiroki Mitsuyama, Kent Wallner, Gregory Merrick, et al.
Cancer|July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancerR Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.
Pageof 18